These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7668198

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. From the control tower: some is better than none and a little bit goes a long way.
    Geffner ME.
    J Pediatr; 2001 Dec; 139(6):766-8. PubMed ID: 11743498
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Delayed diabetic syndrome in type I insulin-dependent diabetes].
    Pou Torelló JM.
    An Esp Pediatr; 1992 Dec; 37 Suppl 51():29-33. PubMed ID: 1492723
    [No Abstract] [Full Text] [Related]

  • 25. Microvascular complications of diabetes.
    He Z, King GL.
    Endocrinol Metab Clin North Am; 2004 Mar; 33(1):215-38, xi-xii. PubMed ID: 15053904
    [No Abstract] [Full Text] [Related]

  • 26. The rationale for glucose control in diabetes mellitus.
    Nathan DM.
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):221-35. PubMed ID: 1612066
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Workshop VIII--Retinopathy, nephropathy, neuropathy, and tight control.
    Lebovitz HE, Vinik AI.
    Am J Med; 1991 Feb 21; 90(2A):80S-84S. PubMed ID: 1994725
    [No Abstract] [Full Text] [Related]

  • 29. Diabetes and rehab.
    Slovik DM.
    Rehab Manag; 1997 Feb 21; 10(2):46-8, 52-3, 116. PubMed ID: 10165951
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The Diabetes Control and Complications Trial (DCCT).
    Keen H.
    Health Trends; 1994 Feb 21; 26(2):41-3. PubMed ID: 10137725
    [Abstract] [Full Text] [Related]

  • 33. Prevention and treatment of diabetic complications.
    Levin ME, Boniuk I, Anderson CB, Avioli LV.
    Arch Intern Med; 1980 May 21; 140(5):691-6. PubMed ID: 6994669
    [No Abstract] [Full Text] [Related]

  • 34. DCCT: implications for diabetes care in the UK.
    Boulton AJ.
    Diabet Med; 1993 Oct 21; 10(8):687. PubMed ID: 8261748
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia.
    Hanssen KF, Bangstad HJ, Brinchmann-Hansen O, Dahl-Jørgensen K.
    Diabet Med; 1992 Oct 21; 9(8):697-705. PubMed ID: 1395460
    [No Abstract] [Full Text] [Related]

  • 39. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.
    Diabetes; 1986 May 21; 35(5):530-45. PubMed ID: 2869996
    [Abstract] [Full Text] [Related]

  • 40. Lessons for pediatricians from the diabetes control and complications trial.
    Malone JI.
    Pediatr Ann; 1994 Jun 21; 23(6):295-9. PubMed ID: 8078706
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.